Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.29
+0.27 (4.49%)
At close: Dec 3, 2025, 4:00 PM EST
6.30
+0.01 (0.16%)
After-hours: Dec 3, 2025, 4:00 PM EST
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $399.44 million as of December 3, 2025. Its market cap has decreased by -19.79% in one year.
Market Cap
399.44M
Enterprise Value
247.07M
1-Year Change
-19.79%
Ranking
Category
Stock Price
$6.29
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $399.44M, an increase of 0.43%. That is a compound annual growth rate of 0.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 382.29M | -6.90% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.30B |
| Johnson & Johnson | 492.95B |
| AbbVie | 397.38B |
| UnitedHealth Group | 297.62B |
| AstraZeneca | 283.73B |
| Merck & Co. | 249.88B |
| Novartis AG | 249.18B |
| Abbott Laboratories | 220.89B |